Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCT
Clinical trial NCT06202625 · RECRUITING
Trial details
- NCT number
- NCT06202625
- Sponsor
- Peking University People's Hospital
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-13
- Primary completion
- 2024-10-30
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.